Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The dynamics and growth of market are influenced by many factors. Tinea versicolor is a common fungal infection of the skin that has led to an increased demand for effective treatments leading to its expansion. A notable cause of the industry’s expansion is an increase in tinea versicolor infections all over the globe. As awareness about this condition increases, more individuals seek medical attention, creating a growing patient pool.
In addition, medical research and technology advancement are essential in driving the Tinea Versicolor Treatment Market. The market is further shaped by on-going efforts to develop innovative and more efficacious treatment options. Pharmaceutical firms spend heavily in the development of novel therapeutic solutions through Research & Development (R&D) which improve patient outcomes and satisfaction. Consequently, there is continuous innovation that causes competition among players in the market as they strive to improve existing treatments or create new ones that will eventually be used by patients therefore promoting growth.
Furthermore, Tinea Versicolor Treatment Market is significantly determined by regulatory landscape. Before any new drug enters market there will have been a need for very strict regulatory approvals that confirm their safety and efficiency. Regulatory bodies form standards and guidelines that companies are supposed to meet thereby affecting general market dynamics. The whole process of gaining regulatory approval can be very time consuming as well as expensive thus impeding entrance of new products into markets; therefore, any change on policies could result into altering marketing trends shaping it both for established and emerging players.
Economic conditions related market factors play a critical role in dictating how Tinea Versicolor Treatment Market moves forward Evidently for patients or healthcare givers with cost being considered as one major factor. Economic changes directly impact healthcare spending therefore insurance coverages affects directly or even adoption of certain drugs occurs at specific times only due to cost variables connected with them For instance, income levels can influence preference for health care services while cultural beliefs also affect use of particular medications.Economic recessions highly contribute towards low affordability of healthcare facilities within a given society.
Global demographic trends contribute significantly to the market dynamics of tinea versicolor treatment. Aging population worldwide results in increased chances of having skin conditions such as tinea versicolor. This segment often has specific treatment needs which drive the market players to look into them and this can be seen as an opportunity on their part. On the other hand, there are young people who also use services because they want to enhance their beauty which causes demand for better treatment options.
Further technological advancement in diagnostic tools and techniques impact Tinea Versicolor Treatment Market by facilitating accurate and timely diagnosis. Advanced diagnostic capabilities ensure early detection of tinea versicolor that facilitates immediate onset of treatment. The patient’s outcome is determined by these factors and it also affects the prescription choice made by healthcare professionals. It is expected that going forward, there will be increasing role in determining the shape of market landscape for diagnosing technologies.
Tinea Versicolor Treatment Market Highlights:
Tinea Versicolor Treatment Market Overview
The Tinea Versicolor Treatment Market is projected to reach USD 374.6 Million by 2030 at 9.2% CAGR during the forecast period 2022-2030. Tinea Versicolor is one of the common types of skin infection. It also called as pityriasis versicolor. In this condition, small and discolored patches of skin occur, mostly affecting the shoulders and trunk.
Increasing prevalence of tinea versicolor, increasing awareness of the disease, rising healthcare expenditure, advanced diagnosis and treatment options, and approval of new antifungal medicines are leading the growth of tinea versicolor treatment market.
In May 2023, Astellas Pharma, the leading provider of therapies for tinea versicolor in Japan, has agreed to purchase Iveric Bio Inc., a US-based pharmaceutical company, for an estimated amount of $5.9 billion. Astellas Pharma will have access to a diverse range of ophthalmology medications with this transaction. Astellas, the third largest pharmaceutical company in Japan in terms of revenue, has successfully concluded its fifth major international purchase since 2019 with the aim of fortifying its pipeline as the patent protection for its main products nears expiration. Refinitiv data reveals that this deal is the second-biggest cross-border purchase made by a Japanese pharmaceutical company in the past five years. The greatest acquisition during this period was Takeda Pharmaceutical Co.'s $6 billion purchase of Nimbus Therapeutics' psoriasis medicine unit, which was revealed in December.
In November 2023, Bayer and Recursion Pharmaceuticals declared their decision to redirect their collaboration towards oncology. This shift entails a change in their focus from net sales royalties and milestone payments to the advancement of up to seven oncology studies. Recursion stands to receive a maximum of $1.5 billion in potential compensation. Recursion has recently announced a $160 million, five-year arrangement with Tempus, granting them exclusive access to more than 20 petabytes of data. The data provided consists of oncology datasets that are focused on patients. These datasets have been de-identified and include patient health records, as well as DNA and RNA information. Furthermore, Recursion announced its plan to increase the computational power of its BioHive-1 supercomputer by fourfold. This will be achieved by procuring more than 500 NVIDIA H100 Tensor Core GPUs, in addition to the existing 300 A100 Tensor Core GPUs that are now in use. The purpose of this expansion was to facilitate and enhance this partnership as well as other similar endeavors.
Study objectives of tinea versicolor treatment market:
- To provide detailed analysis of the tinea versicolor treatment market structure with historical and forecast revenue for the next six years of the various segments and sub-segments.
- To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of tinea versicolor treatment market
- To provide analysis of the market with respect to various countries in the four main geographies– the Americas, Europe, Asia Pacific, and Middle East & Africa.
- To provide detailed analysis of the market segmented by diagnosis, treatment, end user, and its sub-segments.
- To provide a detailed analysis of tinea versicolor treatment market mainly based on Value Chain Analysis, Porter’s Five Forces, Price Analysis, and Supply Chain Analysis etc.
- To provide a detailed country level analysis of the market with respect to the current market size and future prospects
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the tinea versicolor treatment market
- To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the tinea versicolor treatment market
FIGURE 1 TINEA VERSICOLOR TREATMENT MARKET SHARE BY END USER, 2016 (%) 
Sources: DermNet New Zealand Trust, National Center for Biotechnology Information (NCBI), American Academy of Dermatology, U.S. National Library of Medicine, Directorate of Industries, Annual report, White paper, Company Presentation
Intended Audience:
- Tinea versicolor medicines manufacturers
- Tinea versicolor medicines and treatment providers
- Medical research laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Research Methodology:
Sources: DermNet New Zealand Trust, National Center for Biotechnology Information (NCBI), American Academy of Dermatology, U.S. National Library of Medicine, Directorate of Industries, Annual report, White paper, Company Presentation.
Tinea Versicolor Treatment Market Segmentation
Tinea versicolor treatment market has been segmented on the basis of diagnosis which comprise physical exam, imaging tests, and others. Imaging test is sub-segmented into wood lamp (black light) examination, microscopy using potassium hydroxide (KOH), fungal culture, skin biopsy, and others. Skin biopsy is sub-segmented into shave biopsy, punch biopsy, excisional biopsy, and others.
On the basis of treatments, the market has been segmented into antifungal shampoos, antifungal creams, drugs, and others. Antifungal shampoos are sub-segmented into selenium sulfide (selsun) 2.5 percent shampoo, ciclopirox (loprox, penlac) shampoo, ketoconazole (ketoconazole, nizoral, others) shampoo, and others. Antifungal creams are sub-segmented into Selenium sulfide (Selsun) 2.5 percent lotion, Ciclopirox (Loprox, Penlac) cream or gel, Ketoconazole (Ketoconazole, Nizoral, others) cream or gel, and others. Drugs are further sub-segmented into fluconazole (diflucan) tablets or oral solution, and others.
On the basis of end user, it is segmented into dermatology hospital and clinics, medical research centers, academic institutes, and others.
Regional Analysis of Tinea Versicolor Treatment Market
Considering the global scenario of the market, America is the top contributor in this market. The Americas mainly include North America and South America. Due to large amount of money invested in research, clinical trials, and new product development, US is the dominating country in this region. Europe is the second largest market for tinea versicolor treatment. Germany is dominating this market while UK is the fastest growing tinea versicolor treatment market. Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly improving healthcare facilities, increasing awareness of disease, and rising healthcare expenditure. Middle East & Africa is expected to have limited growth.
Key Players for Tinea Versicolor Treatment Market
Some of the key players in this tinea versicolor treatment market are:
- Astellas Pharma US, Inc. (Japan)
- Bayer AG (German)
- Enzon Pharmaceuticals, Inc. (US)
- Galderma S.A. (Switzerland)
- Gilead (US)
- Novartis AG (Switzerland)
- Pfizer Inc. (US)
- Taro Pharmaceutical Industries Ltd. (US)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Valeant (Canada)
The report for Global Tinea Versicolor Treatment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
